[121]
Liver cancer - Cancer survival, incidence and mortality in NSW ...
[143,0 KB]
From [www.cancercouncil.com.au] Last viewed: 07.09.2006
Liver
Cancer survival, incidence and mortality in NSW 1994–2000
26
The Cancer Council NSW
Liver cancer
• The five-year relative survival from liver cancer in NSW between 1994 and 2000 was 12.6%
• The adjusted relative risks of excess death after shrinking were higher in Mid North Coast (33%,
seven excess deaths), and lower in South Eastern Sydney (21%, 34 fewer deaths)
• If the State average risk of excess death was shifted to the 20
th
centile of the distribution, an
additional 119 people with liver cancer in NSW would be expected to survive to five years after
diagnosis
• There were 1,016 new cases of liver cancer in NSW in 1994 to 1998 (749 males and 267
females) and 774 deaths (567 males and 207 females)
• There were more new cases of liver cancer than expected in Central Sydney (38 in males),
Western Sydney (18 in males), South Western Sydney ...
[122]
Microsoft PowerPoint - Radionuclide Treatment of Liver Cancer ...
[547,7 KB]
From [www.nucmediex.net] Last viewed: 07.09.2006
Liver cancer -results
Liver cancer -results
John Buscombe
John Buscombe
Page 2
Methods of treatment
Methods of treatment
Directed to HCC
Directed to HCC
Vascular tumours
Vascular tumours
Supplied by Hep artery
Supplied by Hep artery
(normal liver also Portal vein)
(normal liver also Portal vein)
Ability to deliver radioactivity by catheter
Ability to deliver radioactivity by catheter
2 main methods
2 main methods
Y-90 labelled
Y-90 labelled microspheres
microspheres
Labelled
Labelled Lipiodol/Chitosan
Lipiodol/Chitosan
Page 3
SIR spheres
SIR spheres
They are tiny glass beads
They are tiny glass beads
35 micron in size
35 micron in size
Y-90 within ...
[123]
Liver Cancer and Exposure to Ionizing Radiation Summary ...
[27,0 KB]
From [www.mtafund.org] Last viewed: 07.09.2006
Center for Environmental Health Studies
(617) 482-9485
44 Farnsworth Street, Boston, MA 02210
http://www.jsi.com
*
Findings were statistically significant (strong evidence)
+
Evidence of a dose-response relationship (strongest evidence)
Page 57
Liver Cancer and
(including intra-hepatic bile duct)
Exposure to Ionizing Radiation
Summary:
Moderately strong evidence has been recorded of a possible connection between
liver cancer deaths and exposure to ionizing radiation. This evidence is based upon studies
conducted at Los Alamos National Laboratory, studies of nuclear workers at other sites, and
others exposed to ionizing radiation. These findings are consistent with the National Research
Council’s determination that the liver is sensitive to ionizing radiation. Liver cancer is
designated as a “specified” cancer ...
[124]
Changes in survival patterns in urban Chinese patients with liver ...
[88,4 KB]
From [www.wjgnet.com] Last viewed: 07.09.2006
P.O.Box 2345, Beijing 100023,China
World J Gastroenterol 2003;9(6):1212-1215
Fax: +86-10-85381893
World Journal of Gastroenterology
E-mail: wjg@wjgnet.com
www.wjgnet.com
Copyright © 2003 by The WJG Press ISSN 1007-9327
•
LIVER CANCER
•
Changes in survival patterns in urban Chinese patients with liver
cancer
Xi-Shan Hao, Ke-Xin Chen, Peizhong Peter Wang, Tom Rohan
Xi-Shan Hao, Ke-Xin Chen, Tianjin Cancer Institute and Hospital,
Tianjin Medical University, Tianjin 300060, China
Peizhong Peter Wang, Department of Public Health Sciences,
University of Toronto, Toronto, Canada
Tom Rohan, Department of Epidemiology and Social Medicine,
Albert Einstein College of Medicine, Bronx, U.S.A
Correspondence to: Dr. P. Peter Wang, ACREU, Toronto Western
Hospital Research Institute, University Health Network, MP 10-
327, 399 Bathurst Street, ...
[125]
Liver Cancer (Hepatocellular Carcinoma)
[111,9 KB]
From [www.cpmc.org] Last viewed: 07.09.2006
Overview
Numerous surgical advances and the
involvement of surgeons early in the evalua-
tion of liver lesions have resulted in the
ability to resect more liver malignancies with
lower rates of operative mortality. At
California Pacific, a medical-surgical team
including an oncologist, hepatologist,
radiologist and surgeon work together on
all hepatocellular carcinoma (HCC) cases,
evaluating patients’ability to tolerate a liver
resection or other treatment regimens.
Because time is critical after the diagnosis of
HCC, patients who are not candidates for
resection should be referred immediately for
possible ablative therapy, chemotherapy
and/or liver transplantation if indicated.
Tumor Detection
Initially, liver cancer is hard to detect.
Patients typically don’t feel any differently as
most tumors are asymptomatic. For this
reason, physicians ...
[126]
Liver Cancer
[129,7 KB]
From [p53.cancer.med.umich.edu] Last viewed: 07.09.2006
Last revised: 4/10/03
UM Cancer Center
Patient Education Document #0032
Apr03 Ed.
Online version: http://www.cancer.med.umich.edu/learn/percpathways.htm
University of Michigan Comprehensive Cancer Center
Patient Education Resource Center (PERC)
INFORMATION GUIDE
Liver Cancer
The purpose of this information guide is to help patients newly diagnosed with Liver Cancer and their
families to find sources of information and support. This list is not meant to be comprehensive, but rather to
provide starting points for information seeking. The materials can be found at the Patient Education
Resource Center at the University of Michigan Comprehensive Cancer Center in room B1-361.
Brochure
Available free at the Patient Education Resource Center on Level B-1
National Cancer Institute. What You Need To Know About: Liver Cancer. Full-text
available ...
[127]
Radiofrequency ablation: A good regional therapy for liver cancer ...
[20,6 KB]
From [www.wjgnet.com] Last viewed: 07.09.2006
www.wjgnet.com
P.O.Box 2345, Beijing 100023,China
World J Gastroenterol 2003;9(1): 192
Fax: +86-10-85381893
World Journal of Gastroenterology
E-mail: wcjd@public.bta.net.cn www.wjgnet.com
Copyright © 2003 by The WJG Press ISSN 1007-9327
•
CORRESPONDENCE
•
Radiofrequency ablation: A good
regional therapy for liver cancer
I read the article “Clinical short-term results of
radiofrequency ablation in liver cancers”. World J Gastroenterol
2002 August 15, 8(4): 624-630 by Liu et al with interest.
Radiofrequency ablation is now most common technique
to ablate unresectable liver tumours. We have been using
transarterial chemoembolisation for irresectable HCC bigger
than 5 cm in size before RFA. Have authors have any experience
of combining RFA with trans arterial chemoembolisation?
Recent literature suggests that targeted chemotherapy may
...
[128]
Des- -carboxy prothrombin in cancer and non-cancer liver tissue of ...
[136,5 KB]
From [147.52.72.117] Last viewed: 07.09.2006
Abstract. Des-
Á
-carboxy prothrombin (DCP), also known as
protein induced by vitamin K absence or antagonist II absence
(PIVKA-II), has been considered as a useful serum tumor
marker for hepatocellular carcinoma (HCC). However, the
underlying mechanism causing the elevation of serum DCP
levels in HCC patients remains unclear. This study was under-
taken to identify the relationship between serum DCP levels
and the expression of DCP in cancer and surrounding non-
cancer liver tissues of HCC patients. Serum and tissue
samples prepared from 92 patients with a single HCC nodule
were subjected to clinicopathological study by measuring
serum DCP levels and performing immunohistochemical
staining for tissue DCP. Serum DCP levels correlated
significantly with clinicopathological factors such as hepatitis
markers, tumor differentiation, vascular invasion, intrahepatic
metastasis, TNM ...
[129]
Epidermal growth factor receptor expression in human pancreatic ...
[87,7 KB]
From [147.52.72.117] Last viewed: 07.09.2006
Abstract. Pancreatic cancer is a malignant tumor with an
extremely poor prognosis. The mechanisms of the aggressive
growth and metastasis are not yet extensively understood.
Over-expression of epidermal growth factor receptor (EGFR)
was suggested to be associated with malignant transformation
of pancreatic cancer . We examined EGFR expression in
77 cases of invasive ductal adenocarcinoma of the pancreas,
and analyzed the relation between the EGFR expression pattern
and clinicopathological factors. EGFR immunoreactivity was
detected in 41.6% (32/77) of human pancreatic cancers; i.e.
diffuse expression in 32.5% (25/77) and focal expression in
9.1% (7/77). The EGFR expression was associated with gender
(p<0.05), histological differentiation (p<0.05) and metastatic
status of TNM classification (p<0.01). The observations
suggested that EGFR expression plays important roles in
metastasis, especially ...
[130]
LIVER CANCER STAGE FORM
[39,1 KB]
From [www.stonybrookhospital.com] Last viewed: 07.09.2006
STATE UNIVERSITY OF NEW YORK
UNIVERSITY HOSPITAL AND
MEDICAL CENTER
STONY BROOK, NEW YORK 11794
LIVER
(INCLUDING INTRAPHEPATIC BILE DUCTS)
CANCER STAGE FORM
Type of specimen __
Histopathologic Type
Tumor Size _
TU2C036 (10/02)
Patient Name _
Date of Birth __
MR# __
Enc# __
Sex
Race __
Pt Type: § In § Out § E.D
Clin
Path
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
Clin
Path
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
[ ]
DEFINITIONS
Primary Tumor (T)
TX Primary tumor cannot be assessed
T0 No evidence of primary tumor
T1 ...
[131]
Liver Cancer Surveillance Tools Can Enable Early Diagnosis
[186,9 KB]
From [www.cpmc.org] Last viewed: 07.09.2006
Contents
2
Imaging Techniques Help
Diagnose Previously
Undetected Hepatic
Tumors
2
New Physicians Join
Liver Disease &
Transplant Team
3
Liver Biopsy Offers
Significant Insight for
Managing Hepatitis C
4
Research Uncovers New
Therapies for Treating
Liver Cancer
In cases of fibrolamellar hepatocellular carcinoma,
AFP levels are notoriously normal. To increase the
sensitivity of AFP to 85%, the des-gamma-
carboxyprothrombin (DCP) tumor marker is used
in some institutions, particularly in Japan.
Periodic ultrasound examination offers the best HCC
surveillance tool because it has more sensitivity and
specificity than AFP. However, recommendations
from recent conferences advocate:
• Older patients with cirrhosis or with certain
congenital metabolic conditions known to be
at risk ...
[132]
EPIDEMIOLOGY, PATHOGENESIS, AND PREVENTION OF HEPATITIS B VIRUS ...
[26,5 KB]
From [www.fccc.edu] Last viewed: 07.09.2006
Fox Chase Cancer Center 2001 Scientific Report
EPIDEMIOLOGY, PATHOGENESIS, AND PREVENTION OF
HEPATITIS B VIRUS INFECTION AND LIVER CANCER
W. Thomas London, M.D., Senior Member; Adjunct Professor of Epidemiology, Center for Clinical
Epidemiology and Biostatistics, University of Pennsylvania School of Medicine
Anna P. O’Connell, A.B., Staff Scientist
Manette Fine, D.O., Research Physician
Malick Diene,* M.D., Visiting Scientist, Army Health Service, Dakar, Senegal
Mouhamadou Mbengue, M.D., Visiting Scientist, Army Health Service, Dakar, Senegal
Gang Chen, M.D., Ph.D., Research Associate
Joyce Atleson, R.N., B.F.A., Nurse Coordinator
Gail Duncan, B.S., Scientific Assistant
Lora Pasternak, B.S., Research Specialist
Kathleen Gillespie, Data Technician
Diane Faison, Scientific Technician
Kimberly Newman-McCown, Scientific Technician
Catherine ...
[133]
HEPATITIS VIRUSES AND LIVER CANCER
[61,8 KB]
From [www.fccc.edu] Last viewed: 07.09.2006
Fox Chase Cancer Center 2001 Scientific Report
Depletion of WHV Replication Intermediates
Via a By-stander Effect in a Transgenic
Mouse. Song, Zhou,
d
Mason, in collaboration
with Jilbert,
e
Seeger,
§
Sigal,
§
Rall
§
Previous studies from us and others have
revealed that clearance of transient hepatitis B
virus (hepadnavirus) infections must initiate
with a shut down of virus replication within
infected cells. Moreover, experiments with
HBV transgenic mice have shown that cytok-
ines elaborated by the immune system can
induce a rapid degradation of intermediates in
hepadnavirus replication, effectively shutting
down virus production, without producing any
damage to the infected cell. For example, INF
?
and TFN
a
, produced in response to infection
of only a few percent ...
[134]
Clinical: Pancreatic Cancer Pancreatic Cancer-Associated Diabetes ...
[52,3 KB]
From [www.pancreasweb.com] Last viewed: 07.09.2006
Clinical: Pancreatic Cancer
250
Pancreatic Cancer -Associated Diabetes is Correlated
with Increased Liver Nitric Oxide (NO)
D. Basso, P. Fogar
1
, C. Bassi
3
, A. Valerio
2
, M. Abu-Hilal
3
,
S. Mazza, F. Navaglia, C.-F. Zambon, E. Greco, M. Falconi
3
,
S. Pedrazzoli
1
, M. Plebani
Dept. of Laboratory Medicine,
1
Dept. of Medical and Surgical
Sciences,
2
Clin. and Experimental Medicine, Padova;
3
Dept of Surgery and Gastroenterology, Pancreatic Unit,
Verona, Italy
Background: In pancreatic cancer -associated diabetes mellitus (PC-DM) an altered
liver and muscle glucose metabolism occurs. NO modifies glucose release by isolated
hepatocytes. Our aims were to verify whether PC-DM determines in the liver ...
[135]
Chronic liver injury, TGF- ß , and cancer
[129,6 KB]
From [www.e-emm.org] Last viewed: 07.09.2006
EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 33, No. 4, 179-190, December 2001
Chronic liver injury, TGF- ß , and cancer
D. Montgomery Bissell
1,2
1
University of California, San Francisco
2
Corresponding author: Fax, +1-415-476-0659;
E-mail, dmbiss@itsa.ucsf.edu
Accepted 19 November 2001
Abbreviations: ECM, extracellular metrix; HSC, hepatic stellate cell;
HCC, hepatocellular carcinoma
Abstract
Cells termed myofibroblasts are prominent in the
injury response of all epithelial tissues. They exhibit
proliferation, migration, production of collagen and
other extracellular matrix (ECM) molecules, and con-
traction, all for containing the injury and closing the
wound. When the injury is limited in time, the final
stage of the repair involves a dismantling of the cel-
lular apparatus and restoration of normal tissue ...
[136]
P2 CANCER. BASIC ASPECTS Obstructive Jaundice Results in Increased ...
[19,9 KB]
From [www.pancreasweb.com] Last viewed: 07.09.2006
P2 CANCER . BASIC ASPECTS
78
Obstructive Jaundice Results in Increased Liver
Expression of Uncoupling Protein 2 and Intact
Skeletal Muscle Glucose Metabolism in the Rat
Bengt Isaksson
1
, Catarina Rippe
2
, Rusana Simonoska
1
, Jan-Erik Holm
1
,
Ralf Segersvärd
1
, Jörgen Larsson
1
, Charlotte Erlanson-Albertsson
2
,
Johan Permert
1
Arvid Wretlind Laboratory for Metabolic and Nutritional Research
1
,
Department of Surgery, Karolinska Institute at Huddinge University Hospital,
S-141 86 Stockholm, Sweden, Department of Medical Chemistry
2
,
Lunds University Hospital, Lund, Sweden
Background and Aims : A majority of patients with pancreatic cancer have obstructive
jaundice and diabetes with skeletal muscle insulin ...
[137]
8. MALIGNANT CANCER OF THE LIVER AND INTRAHEPATIC BILE DUCTS (summary)
[13,5 KB]
From [www.allirelandnci.org] Last viewed: 07.09.2006
All-Ireland cancer statistics 1994-96
50
Liver and intrahepatic bile ducts
8. MALIGNANT CANCER OF THE LIVER AND
INTRAHEPATIC BILE DUCTS (summary)
ICD-O.2 C22
ICD-10 C22
ICD-9 155
Key facts
•
Average of 113 new cases per year, 1994-96: 43 cases in females, 70 in males.
•
Average of 192 deaths per year: 80 in females, 112 in males.
•
Age-standardised incidence and mortality rates about twice as high in males as in females.
•
11th most common cause of cancer deaths in males, 12th in males.
•
Incidence rates in Northern Ireland (NI) about 130% higher for females, 50% for males, than the Republic (RoI).
•
Incidence rates well below EU 1995 averages.
Summary statistics
Table 8.1
Incidence 1994-96
Primary, malignant cancer of the liver and intrahepatic bile ducts is uncommon. On average each ...
[138]
EPIDEMIOLOGY, PATHOGENESIS, AND PREVENTION OF HEPATITIS B VIRUS ...
[38,5 KB]
From [www.fccc.edu] Last viewed: 07.09.2006
332
Population Science Division
Gender and Risk of Hepatocellular Carcinoma
in the Haimen City Cohort. Chen, London, in
collaboration with Evans,§ Ross,
§
Balshem,
§
Shen,
b
Lin,
c
Fan,
d
Haimen City Cooperating
Group
Haimen City is located on the north bank
of the Yangtze River, about 50 miles west of
Shanghai, P.R. China. It is primarily an agricul-
tural area, but does have small factories widely
distributed among all the villages and town-
ships. About 75% of the one million inhabitants
are farmers. HCC has long been known to be a
major medical and public health problem in
this community. In order to identify the specific
environmental, viral and genetic factors that
may affect risk of HCC and the interaction of
such factors, a prospective study was initiated in
Haimen City between ...
[139]
HEPATITIS VIRUSES AND LIVER CANCER
[74,0 KB]
From [www.fccc.edu] Last viewed: 07.09.2006
Basic Science Division
105
The Role of Hepatocyte Regeneration in the
Clearance of Hepadnavirus Infections from
the Liver . Zhu, Yamamoto, Saputelli, Aldrich,
Mason, in collaboration with Cullen,
b
Litwin,
§
Furman,
c
Jilbert
d
Hepatitis B viruses cause chronic and pro-
ductive infections of hepatocytes. New viral
DNA is produced by reverse transcription,
which occurs in the cytoplasm, but viral RNA is
transcribed from a covalently closed circular
form of viral DNA (cccDNA) that is only found
in the nucleus. The goal of antiviral therapy is to
eliminate not just the viral DNAs in the cyto-
plasm, but also the cccDNA in the nucleus.
Inhibitors of the hepatitis B virus DNA poly-
merase block new viral DNA synthesis, so that
these DNAs are quickly cleared from the cyto-
plasm of the infected cell. However, cccDNA ...
[140]
Mechanisms Involved in Trichloroethylene-Induced Liver Cancer ...
[89,6 KB]
From [www.osti.gov] Last viewed: 07.09.2006
1
54684: Mechanisms Involved in Trichloroethylene-Induced Liver
Cancer : Importance to Environmental Cleanup
(First Year of Funding: 1996)
DOE report Number:
3/1/00
Principal Investigator
Richard J. Bull, Ph.D.
Pacific Northwest National Laboratory
P.O. Box 999, MSIN P7-56
Richland, WA 99352
(509) 373-6218 (phone)
Dick.bull@pnl.gov
Co-Principal Investigator
Brian D. Thrall
Pacific Northwest National Laboratory
P.O. Box 999, MSIN P7-56
Richland, WA 99352
(509) 376-3809 (phone)
Brian.thrall@pnl.gov
Contributors
Lyle B. Sasser (Lyle.sasser@pnl.gov)
John H. Miller (John.h.miller@pnl.gov)
Irvin R. Schultz (Irvin.schultz@pnl.gov)
Graduate Students
Anja J. Stauber
Alberto Gonzalez-Leon
Junko Kato-Weinstein
James Merdink
Melissa K. Linghor
Page 2 ...
[141]
UNIT V: Models of Liver Cancer, Non Genotoxic Carcinogens
[161,1 KB]
From [mcardle.oncology.wisc.edu] Last viewed: 07.09.2006
Bradfield; Mechanisms of Liver Carcinogenesis
18
UNIT V: Models of Liver Cancer , Non Genotoxic Carcinogens
Assigned Reading:
Pitot et al. (1996). Quantitation of multistage carcinogenesis in rat liver . Toxicologic
Pathology. 24:119.
1) Not all carcinogens are genotoxic, (i.e., directly alkylate DNA and cause mutations).
2) Chemicals that enhance carcinogenic responses to genotoxic carcinogens are known as promoters.
3) Modeling HCC in rodents can be performed by monitoring the evolution of carcinogen induced
enzyme altered foci.
Non Genotoxic Carcinogens:
Until now, we have been talking about carcinogens that act via direct/covalent modification of DNA (“alkylation”).
We have talked about the early proposal that all carcinogens are mutagens. From the initial DNA alkylation
studies and mutagenicity studies came the classification of mutagenic/alkylating carcinogens ...
[142]
UNIT I: Liver Biology, Pathology and Cancer
[130,7 KB]
From [mcardle.oncology.wisc.edu] Last viewed: 07.09.2006
Bradfield; Mechanisms of Liver Carcinogenesis
1
Chris Bradfield, 262-2024
213 McArdle , Bradfield@oncology.wisc.edu
Assignments: Each lecture summary sheet will have questions within the text that are bold
and in italics. Please be prepared to answer these questions in class. In addition written
short answers to these same questions will be due four times throughout the next few weeks.
I will assign the exact dates in class depending on how fast we move through the material.
Assigned Reading for unit I: These readings are meant to provide background.
1) Briefly review liver physiology before the first session (any physiology text will do).
2) Venook, AP (1994). Hepatocellular carcinoma: Too many options? J. Clin. Oncology.
12:1323.
UNIT I: Liver Biology, Pathology and Cancer
It is important to understand liver biology, pathology and cancer because:
...
[143]
EPIDEMIOLOGY, PATHOGENESIS, AND PREVENTION OF HEPATITIS B VIRUS ...
[25,6 KB]
From [www.fccc.edu] Last viewed: 07.09.2006
Population Science Division
329
EPIDEMIOLOGY, PATHOGENESIS, AND PREVENTION OF
HEPATITIS B VIRUS INFECTION AND LIVER CANCER
W. Thomas London, M.D., Senior Member; Adjunct Professor of Epidemiology, Center for
Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine
Anna P. O’Connell, A.B., Staff Scientist
Manette Fine, D.O., Research Physician
Malick Diene, M.D., Visiting Scientist, Army Health Service, Dakar, Senegal
Gang Chen, M.D., Ph.D., Postdoctoral Associate
Long-Long Gao, M.D., Graduate Student, University of Pennsylvania School of Medicine
Marla Snyder, B.A., Research Data Coordinator
Joyce Atleson, R.N., B.F.A., Nurse Coordinator
Gail Duncan, B.S., Technical Specialist
Lora Pasternak, B.S., Research Specialist
Kathleen Gillespie, Data Technician
Diane Faison, Scientific Technician
Jeffry Saputelli, ...
[144]
152-03 (7-19-97) Hepatitis B shots reduce liver cancer
[41,1 KB]
From [www.sciencenews.org] Last viewed: 07.09.2006
Hepatitis B shots reduce liver cancer
In July 1984, Taiwan instituted a free, nationwide vaccination campaign against the hepati-
tis B virus. The program started with infants, but by the end of the 1980s, preschool and
school-age children were also getting the shots. Predictably, hepatitis B cases in Taiwanese
children declined by more than 90 percent between 1984 and 1994.
Now, a review of Taiwan’s national cancer registry shows that the incidence of liver cancer
in Taiwanese children has dropped dramatically as well. Researchers had suspected the same
virus often underlies both diseases.
To gauge the cancer decline, Taiwanese researchers documented all 294 cases of hepatocel-
lular carcinoma, the most common liver cancer , between 1981 and 1994 in children age 6 to
14. The number of cases fell from 26 in 1982 to 8 in 1993, Mei-Hwei Chang’s team at the
National Taiwan University in Taipei reports in ...
[145]
Mechanism Involved in Trichloroethylene-Induced Liver Cancer ...
[175,1 KB]
From [www.osti.gov] Last viewed: 07.09.2006
Project ID: 54684
Project Title: Mechanism Involved in Trichloroethylene-Induced Liver Cancer :
Importance to Environmental Cleanup
Lead Principal Investigator :
Dr. Richard J. Bull
Pacific Northwest National Laboratory
MSIN P7-56
P. O. Box 999
Richland, Washington 99352
Telephone: 509-373-6218
e-mail: Dick.bull@pnl.gov
Co Principal Investigators:
Brian D. Thrall
Pacific Northwest National Laboratory
P.O. Box 999
MSIN P7-56
Richland Washington 99352
Telephone: (509) 376-3809
e-mail: Brian.thrall@pnl.gov
Page 2
5.2
Mechanisms Involved in Trichloroethylene-Induced Liver Cancer :
Importance to Environmental Cleanup
(First Year of Funding: 1996)
Principal Investigator
Richard J. Bull, Ph.D.
Pacific Northwest National Laboratory
P.O. Box 999, MSIN P7-56
Richland, WA 99352 ...
[146]
LIVER CANCER
[61,7 KB]
From [www.vandenberg.af.mil] Last viewed: 07.09.2006
A
BASIC INFORMATION
DESCRIPTION
Uncontrolled growth of malignant cells in the liver .
Liver cancer may be primarily resulting from abnormal
liver or bile-duct cells, or it may result from spread of
cancer from another site (metastases). The most com-
mon sources are cancers of the rectum, colon, lung,
breast, pancreas, esophagus or skin (malignant
melanoma). Liver cancer can affect all ages, but is most
common in men over 60.
FREQUENT SIGNS AND SYMPTOMS
• Loss of appetite and weight loss.
• Tender mass in the right upper abdomen.
• Pain in the upper abdomen.
• Low fever, usually less than 101°F (38.3°C).
• Yellow eyes and skin (sometimes).
• Swollen abdomen from fluid retention (sometimes).
• Lethargy.
CAUSES
Unknown. It occurs most often in population groups
with a high incidence of viral hepatitis and other chronic
liver diseases.
...
[147]
Ten Years Later: Liver Cancer Treatment Reevaluated
From [jncicancerspectrum.oxfordjournals.org] Last viewed: 07.09.2006
research for a cure
laboratory without walls
National Foundation for Cancer Research
Cancer FAQs
about liver cancer
Frequently Asked Questions about common cancers.
Page 2
Cancer FAQs
What are the different types of liver cancer ?
There are many kinds of tumors than can originate in the liver . Of the
four main types that are cancerous (angiosarcomas, cholangiocarcinomas,
hepatoblastomas, and hepatocellular carcinomas), hepatocellular carcinoma
(also called hepatoma or HCC), is by far the most common, accounting
for about 84 percent of all liver cancer cases. HCC starts growing in the
hepatocytes, the main type of cell found in the liver .
What are the risk factors for liver cancer ?
A risk factor is anything that increases a person’s chance of getting a
disease. There are several known risk factors ...
[148]
Early Detection and Treatment of Liver Cancer Kunio Okuda ...
From [jncicancerspectrum.oxfordjournals.org] Last viewed: 07.09.2006
research for a cure
laboratory without walls
National Foundation for Cancer Research
Cancer FAQs
about liver cancer
Frequently Asked Questions about common cancers.
Page 2
Cancer FAQs
What are the different types of liver cancer ?
There are many kinds of tumors than can originate in the liver . Of the
four main types that are cancerous (angiosarcomas, cholangiocarcinomas,
hepatoblastomas, and hepatocellular carcinomas), hepatocellular carcinoma
(also called hepatoma or HCC), is by far the most common, accounting
for about 84 percent of all liver cancer cases. HCC starts growing in the
hepatocytes, the main type of cell found in the liver .
What are the risk factors for liver cancer ?
A risk factor is anything that increases a person’s chance of getting a
disease. There are several known risk factors ...
[149]
Worldwide Immunization Program Targets Hepatitis B and Liver Cancer
From [jncicancerspectrum.oxfordjournals.org] Last viewed: 07.09.2006
research for a cure
laboratory without walls
National Foundation for Cancer Research
Cancer FAQs
about liver cancer
Frequently Asked Questions about common cancers.
Page 2
Cancer FAQs
What are the different types of liver cancer ?
There are many kinds of tumors than can originate in the liver . Of the
four main types that are cancerous (angiosarcomas, cholangiocarcinomas,
hepatoblastomas, and hepatocellular carcinomas), hepatocellular carcinoma
(also called hepatoma or HCC), is by far the most common, accounting
for about 84 percent of all liver cancer cases. HCC starts growing in the
hepatocytes, the main type of cell found in the liver .
What are the risk factors for liver cancer ?
A risk factor is anything that increases a person’s chance of getting a
disease. There are several known risk factors ...
[150]
Transplants for Liver Cancer Show Promise, Not Proof
[3642,8 KB]
From [jncicancerspectrum.oxfordjournals.org] Last viewed: 07.09.2006
research for a cure
laboratory without walls
National Foundation for Cancer Research
Cancer FAQs
about liver cancer
Frequently Asked Questions about common cancers.
Page 2
Cancer FAQs
What are the different types of liver cancer ?
There are many kinds of tumors than can originate in the liver . Of the
four main types that are cancerous (angiosarcomas, cholangiocarcinomas,
hepatoblastomas, and hepatocellular carcinomas), hepatocellular carcinoma
(also called hepatoma or HCC), is by far the most common, accounting
for about 84 percent of all liver cancer cases. HCC starts growing in the
hepatocytes, the main type of cell found in the liver .
What are the risk factors for liver cancer ?
A risk factor is anything that increases a person’s chance of getting a
disease. There are several known risk factors ...